Valeed Bin Mansoor, Usman Ahmed, Muhammad Jahanzaib, Zeeshan Ali, Muhammad Asad Haroon, Hanan Ahmed, Abdul Munim.
End Treatment Response in Chronic Hepatitis C Patients to Sofosbuvir and Ribavirin.
Ann Pak Inst Med Sci Jan ;12(3):127-30.

Objective: To investigate the end treatment response of Sofosbuvir and Ribavirin in chronic hepatitis C patients and determine the efficacy of this drug combination. Study Design: Retrospective study Place and Duration: September 15th 2015 and May 19th 2016 Materials and Methods: A total of 153 cases were taken who attended the hospital between September 15th 2015 and May 19th 2016 were included in this study and had their PCR done at 4 and 24 months. It comprises of both treatment naive (those who had not been treated previously for Hepatitis C) and treatment experienced (those who had previous treatment failure for hepatitis C or relapse, either due to the drug intolerance, drug resistance and/or other factors). SPSS v21 was used to analyze the data. Results: The end treatment response with aforementioned combination was calculated for 153 cases in which 96.07% responded to the therapy irrespective of their genotypes, type 3 being the most encountered in this study. There was no difference in treatment responses between males and females and p value came out > .05 Conclusion: Drug Combination’s(Sofosbuvir and Ribavirin) efficacy was demonstrated in chronic hepatitis C patients. It was seen to be a very effective combination for the treatment compared to older regimens. Although this requires further studies to confirm the findings our study emphasize that this therapy should be made readily available.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com